Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LABCORP HOLDINGS INC. Director's Dealing 2020

Jul 10, 2020

30237_dirs_2020-07-10_ff6928fc-352b-49cb-acba-a0624045efa0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2020-07-08

Reporting Person: Williams R Sanders (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-07-08 Common Stock M 1300 $98.49 Acquired 6395 Direct
2020-07-08 Common Stock S 1300 $173.12 Disposed 5095 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-07-08 Non-qualified Stock Options $98.49 M 1300 Disposed 2021-05-11 Common Stock (1300) Direct

Footnotes

F1: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.

F2: Director stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2008 Stock Incentive Plan.

F3: The option vested in three equal annual installments beginning on the date reflected in this column and is now fully exercisable.